Gesundheit & Forschung:
A mother-and-son team who have been developing what they hope will be the world’s 1st oral insulin capsule say marketing could begin in 5 years if all goes well.
Just 11 people work inside a 150-sq.m. rented prefab building in the “Hi-Tech Village” on the edge of the Hebrew University of Jerusalem’s Givat Ram campus. The Oramed Pharmaceuticals company, which until a few weeks ago occupied an even-smaller space a few steps away, buys only secondhand furniture – not because CEO Nadav Kidron and chief scientific officer Miriam Kidron – his biochemist mother – are cheapskates. They are just modest, and Oramed is a public company with stockholders and investors behind it….